Rapid induction of p21(WAF1) but delayed down-regulation of Cdc25A in the TGF-β-induced cell cycle arrest of gastric carcinoma cells

British Journal of Cancer

Volumn 80, Issue 8, 1999, Pages 1144-1149

  Kang, S H ^a   Bang, Y J ^a,c   Jong, H S ^a   Seo, J Y ^a   Kim, N K ^a   Kim, S J ^b  

^a Seoul National University College of Medicine   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Seoul National University Hospital   (South Korea)

Author keywords

Cdc25A; cdk inhibitors; Cell cycle arrest; Gastric cancer cells; p21(WAF1); TGF

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PROTEIN P15; PROTEIN P21; PROTEIN P27; TRANSFORMING GROWTH FACTOR BETA; CDC25A PROTEIN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; STOMACH CARCINOMA; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; STOMACH TUMOR;

CDC25 PHOSPHATASE; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DOWN-REGULATION; HUMANS; PROTEIN-TYROSINE-PHOSPHATASE; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032588657     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690478     Document Type: Article

References (26)

1. Alexandorw MG and Moses HL (1995) Transforming growth factor β and cell cycle regulation. Cancer Res 55: 1452-1457
2. Carmichael J, Degraff WG, Gazdar AF, Minna JD and Mitchell JB (1987) Evaluation of tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942
3. Chomezynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
4. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y and Wang X (1995) Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92: 5545-5549
5. Ewen ME, Sluss HK, Whitehouse LL and Livingston DM (1993) TGF-β inhibition of CDK4 synthesis is linked to cell cycle arrest. Cell 74: 1009-1020
6. Filmus J and Kerbel R (1993) Development of resistant mechanisms to the growth inhibitory effects of transforming growth factor-β during tumor progression. Curr Opin Oncol 5: 123-129
7. Geng Y and Weinberg RA (1993) Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 90: 10315-10319
8. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261
9. Iavarone A and Massague J (1997) Repression of the CDK activator Cdc25A and cell cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387: 417-422
10. Kaelin WG, Pallas DC, Decaprio JA, Kaye FJ and Livingston DM (1991) Identification of cellular proteins that can interact specifically with the T/EIA binding region of the retinoblastoma gene product. Cell 64: 521-532
11. Kim JH, Takahashi T, Chiba I, Park JG, Birrer MJ, Roh JK, Lee HD, Kim JP, Minna JD and Gazdar AF (1991) Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl Cancer Inst 83: 938-943.
12. INK1B genes in gastric carcinomas. Cancer 80: 1889-1896
13. Li C, Suardet L and Little JB (1995) Potential role of WAFI/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J Biol Chem 270: 4971-4974
14. Markowitz SD and Roberts AB (1996) Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 7: 93-102
15. Massague J (1990) The transforming growth faclor β family. Annu Rev Cell Biol 6: 597-641
16. Nasmyth K and Hunt T (1993) Cell cycle. Dams and sluices. Nature 366: 634-635
17. Park JG, Frucht H, Larocca RV, Bliss DP Jr., Kurita Y, Chen T, Henslee JG, Trepel JB, Jensen RT, Johnson BE, Bang Y-J, Kim JP and Gazdar AF (1990) Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50: 2773-2780
18. Park JG, Yang HK, Kim WH, Chung JK, Kang MS, Lee JH, Oh JH, Park HS, Yeo KS, Kang SH, Song SY, Kang YK, Bang Y-J, Kim YI and Kim JP (1997) Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 70: 443-449
19. Park K, Kim S-J, Bang Y-J, Park JG, Kim NK, Roberts AB and Sporn MB (1994) Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91: 8772-8776
20. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Munger K, Howley MR and Moses HL (1990) TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61: 777-785
21. Polyak K (1996) Negative regulation of cell growth by TGF-β. Biochem Biophys Acta 1242: 185-199
22. Kip1, a cyclin-CDK inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22
23. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66
24. Reynisdottir I, Polyak K, Iavarone A and Massague J (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 9: 1831-1845
25. CIPI and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol Cell Biol 17: 4338-4345
26. Wrana JL, Attisano L, Wieser R, Ventura F and Massague J (1994) Mechanism of activation of the TGF-β receptor. Nature 370: 341-347